Plant Genetics

We create new plant genetics by breeding strains with specific cannabinoid and terpene profiles and license existing proprietary genetics to legally-authorized distributors, producers, processors, formulators and regulators. We also license existing proprietary genetics through a royalty structure.

Officially licensed GHM strains are bred and collected according to Good Agricultural Collection Practices for Medicinal Plants and are fully traceable. These GHM proprietary genetics are promoted through our marketing channels.

While one of our major aims is to reduce the psychoactive properties of our extracts, we  breed plants for a variety of cannabinoids including THCa, CBDa, and THCVa.

To date, we have evidence for the therapeutic potential of ECS modulators in over 50 diseases including major public health threats such as cancer, Alzheimer’s disease, obesity, diabetes, epilepsy, Parkinson’s disease and depression.

Once we have identified the optimal formulation for any particular disease, we intend to breed new varieties, which confer these specific genetic traits.

We have access to one of the world’s largest genetic libraries of medicinal plant varieties. Our library includes several unique landraces, which were obtained by the Strain Hunters on expeditions to the most remote regions of the world and will serve as a starting point for further genetic development.